Tobin W Juvenal

Chief Commercial Officer

Tobin W Juvenal (Chief Commercial Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $527K of CSTL (20,863 sh × $25.24, as filed), executed Mar 12.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.2M

shares × price, as filed

Last traded

Sep 15

Filed Sep 16

Median ADV $11.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

CSTL

Castle Biosciences, Inc. CSTL · 0 buys · 8 sells 8 filings

Recent filings

CSTLSALE Castle Biosciences, Inc. View filing → $223K
6,600 sh across 2 lots
Exec Sep 14
Filed Sep 16 · 4:20 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $317K
9,050 sh × $35.04
Exec Aug 25
Filed Aug 27 · 4:38 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $450K
15,419 sh across 2 lots
Exec Jul 31
Filed Aug 4 · 4:36 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $527K
20,863 sh × $25.24
Exec Mar 12
Filed Mar 16 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $495K
13,200 sh × $37.48
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $167K
4,693 sh × $35.58
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $125K
3,507 sh × $35.56
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $110K
3,100 sh × $35.39
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET